Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFQRFQ Meaning: What Is an RFQ?
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Library of Pharmacologically Active Compounds (LOP

U.S. Department Of Health And Human Services·Maryland

Library of Pharmacologically Active Compounds (LOP

Closes 8/24/2026$100k – $500kRequest for Quotation
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The National Institutes of Health (NIH) is seeking a contractor to provide a Library of Pharmacologically Active Compounds (LOPAC) for a period of performance from 09/04/2026 to 12/03/2026. The contractor will be required to furnish all necessary services, qualified personnel, material, equipment, and facilities to perform the Statement of Work. The scope of work includes a Broad Institute pooled cancer cell line drug sensitivity study that tests a compound against approximately 900 barcoded cancer cell lines in a shared five-day assay. The contractor will provide data detailing the viability of all 900 cell lines, metrics for the quality of the assay, univariate and multivariate feature set correlation analysis, and all the raw data from NCATS test agents. • The contractor will be responsible for performing the study and providing the results to NCATS through the PRISM Portal. • The contractor will be required to keep all data and information confidential. • The contractor will be required to provide a written notice of award or acceptance of an offer. • The Government reserves the right to accept any offer before the expiration date. • The contractor will be evaluated based on price, technical capability, past performance, and delivery schedule.

Attached files

Contact

Jaddua Johnston(Contracting Specialist)

[email protected]

(240) 569-0006

Key dates

Opened
8/7/2026
Closes
8/24/2026
Duration
90 days

Last updated

Details

Type
Request for Quotation
Industry
Healthcare and Medical Services
NAICS
325412
Solicitation №
75N98026Q00991

Budget estimate

$100,000 – $500,000

Based on the information provided, it is difficult to estimate the exact budget for this opportunity. However, considering the scope of work and the fact that it is a firm-fixed-price contract, the budget could be in the range of $100,000 to $500,000. This estimate is based on the assumption that the contractor will need to provide specialized equipment, personnel, and facilities to perform the study, and that the Government will be paying for the costs associated with the study. Factors that may influence the likely payment range include the complexity of the study, the number of cell lines being tested, and the level of expertise required to perform the study.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Department Of Health And Human Services·United States of America

Top match · 65%

Synthesis and Distribution of Drugs of Abuse and Related Compounds

Closes 11/20/2026Opened 10/29/2026

U.S. Department Of Defense·Pennsylvania

64% match

Bicalutamide Tablets

Closes 11/1/2026Opened 9/2/2026

U.S. Food and Drug Administration·United States of America

64% match

Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. National Institutes of Health·United States of America

64% match

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development

Closes 6/15/2027Opened 7/7/2026

U.S. Department Of Defense·United States of America

64% match

Bicalutamide Tablets

Closes 11/1/2026Opened 9/2/2026

U.S. Department Of Health And Human Services·United States of America

64% match

Synthesis and Distribution of Drugs of Abuse and Related Compounds

Closes 11/20/2026Opened 10/29/2026

U.S. National Institutes of Health·United States of America

63% match

A Holistic Approach to Study Non-Addictive Natural Products for Pain Management

Closes 5/24/2027Opened 4/22/2026

U.S. National Institutes of Health·United States of America

62% match

CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)

Closes 11/5/2028Opened 6/30/2025

U.S. National Institutes of Health·United States of America

62% match

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

Closes 11/18/2027Opened 11/20/2024

U.S. Department Of Defense·Pennsylvania

62% match

Epinephrine Injector

Closes 11/2/2026Opened 4/29/2026

U.S. Department Of Energy·Ohio

62% match

TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform

Closes 12/3/2026Opened 6/4/2026

U.S. National Institutes of Health·United States of America

62% match

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Closes 11/5/2027Opened 11/15/2021

U.S. National Institutes of Health·United States of America

61% match

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

Closes 1/15/2027Opened 9/18/2024

Oregon Health and Science University·Oregon

61% match

Clinical Taxonomy

Rolling / TBD closeOpened 1/1/2017

University of Texas MD Anderson Cancer Center·Texas

61% match

Discovery and Development of Small Molecules and Biologic Therapies RFP

Closes 12/9/2026Opened 10/30/2026

U.S. Department Of Energy·New Mexico

61% match

TECHNOLOGY LICENSING OPPORTUNITY: True Silicone DLP Printing Platform

Closes 1/6/2027Opened 6/29/2026

U.S. Department Of Defense·Pennsylvania

60% match

Methylphenidate ER

Closes 11/6/2026Opened 9/23/2026

U.S. National Institutes of Health·United States of America

60% match

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. Food and Drug Administration·United States of America

60% match

Minor Use Minor Species Development of Drugs (R01)

Rolling / TBD closeOpened 11/30/2023

U.S. National Institutes of Health·United States of America

60% match

HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

Closes 2/20/2029Opened 5/28/2025

U.S. National Institutes of Health·United States of America

60% match

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Closes 8/18/2027Opened 10/1/2024

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

60% match

DoW Toxic Exposures Investigator Initiated Research Award

Closes 11/19/2026Opened 5/7/2026

U.S. National Institutes of Health·United States of America

60% match

Network of the National Library of Medicine Regional Medical Libraries (UG4 Clinical Trial Not Allowed)

Closes 12/14/2026Opened 2/11/2026

Metropolitan Council·Minnesota

60% match

Occupational Health Medical, Drug and Alcohol Collections, Lab, and TPA Services

Closes 11/19/2026Opened 10/14/2026

U.S. Department Of Defense·Virginia

60% match

Atomically Precise Molecules (APM)

Closes 12/18/2026Opened 10/8/2026